Literature DB >> 8076691

Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-kappa B by TNF.

H Albrecht1, J Tschopp, C V Jongeneel.   

Abstract

The recent demonstration of the anti-oxidant properties of the Bcl-2 gene product suggested that expression of Bcl-2 may interfere with the nuclear migration of the NF-kappa B transcription factor, which is thought to depend on the presence of reactive oxygen intermediates. In mouse L cells, overexpression of Bcl-2 interfered with the activation of NF-kappa B by H2O2. However, Bcl-2 had no effect on the activation of NF-kappa B by TNF, even though it protected cells from TNF-induced apoptosis. The effects of exogenous pyrrolidine dithiocarbamate were very similar to those of Bcl-2 overexpression. We conclude that the protective effects of anti-oxidants against induced apoptotic cell death are unrelated to their ability to interfere with NF-kappa B activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8076691     DOI: 10.1016/0014-5793(94)00817-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Gene expression profiling of diabetic and galactosaemic cataractous rat lens by microarray analysis.

Authors:  E Kubo; D P Singh; Y Akagi
Journal:  Diabetologia       Date:  2005-03-11       Impact factor: 10.122

2.  Lactosylceramide is required in apoptosis induced by N-Smase.

Authors:  Sergio F Martin; Niesha Williams; Subroto Chatterjee
Journal:  Glycoconj J       Date:  2006-05       Impact factor: 2.916

3.  Contrasting effects of matrix protein on apoptosis in HeLa and BHK cells infected with vesicular stomatitis virus are due to inhibition of host gene expression.

Authors:  Sarah A Kopecky; Douglas S Lyles
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB.

Authors:  A Z Badrichani; D M Stroka; G Bilbao; D T Curiel; F H Bach; C Ferran
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

5.  Bcl-2 blocks 2-methoxyestradiol induced leukemia cell apoptosis by a p27(Kip1)-dependent G1/S cell cycle arrest in conjunction with NF-kappaB activation.

Authors:  Christina Batsi; Soultana Markopoulou; Evangelos Kontargiris; Christiana Charalambous; Christoforos Thomas; Savvas Christoforidis; Panagiotis Kanavaros; Andreas I Constantinou; Kenneth B Marcu; Evangelos Kolettas
Journal:  Biochem Pharmacol       Date:  2009-03-27       Impact factor: 5.858

6.  Glutathione peroxidase 4 differentially regulates the release of apoptogenic proteins from mitochondria.

Authors:  Hanyu Liang; Qitao Ran; Youngmok Charles Jang; Deborah Holstein; James Lechleiter; Tiffany McDonald-Marsh; Andrej Musatov; Wook Song; Holly Van Remmen; Arlan Richardson
Journal:  Free Radic Biol Med       Date:  2009-05-15       Impact factor: 7.376

Review 7.  Programmed cell death and radioresistance.

Authors:  R E Meyn; L C Stephens; L Milas
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

8.  Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy.

Authors:  Danny Rogers; Karen D Nylander; Zhiping Mi; Tong Hu; Nina F Schor
Journal:  Cancer Chemother Pharmacol       Date:  2008-03-13       Impact factor: 3.333

9.  Constitutive nuclear NF kappa B/rel DNA-binding activity of rat thymocytes is increased by stimuli that promote apoptosis, but not inhibited by pyrrolidine dithiocarbamate.

Authors:  A F Slater; M Kimland; S A Jiang; S Orrenius
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

10.  Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insight and potential therapeutic utility.

Authors:  Neal B Blatt; Jeffrey J Bednarski; Roscoe E Warner; Francesco Leonetti; Kathryn M Johnson; Anthony Boitano; Raymond Yung; Bruce C Richardson; Kent J Johnson; Jonathan A Ellman; Anthony W Opipari; Gary D Glick
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.